Fiducial Markers Market Report
RA01518
Fiducial Markers Market, by Product (Metal-based Markers, Polymer-based Markers, Other Fiducial Markers), End User (Hospitals & Outpatient Facilities, Independent Radiotherapy Centers, Cancer Research Centers), Modality (CT/CBCT, MRI, Ultrasound, Radiotherapy), Cancer Type (Prostate Cancer, Lung Cancer, Breast Cancer, Gastric Cancer, Other Cancers): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global fiducial markers market is estimated to surpass $133.0 million by 2027, exhibiting a CAGR of 4.3% from 2020 to 2027.
The report aims to cater scrupulous analysis of the global fiducial markers market by methodically reviewing different facets of the market such as key segments, market dynamics, regional market circumstances, investment opportunities, and top players operating in the market.
In addition, the report offers insights on the current lookout and upcoming trends and developments that are likely to contribute to the growth of the market. Moreover, major factors such as market drivers and opportunities that are expected to shape the panorama of the global market are deliberated in the report. Also, limitations and threats that hold the power to hinder the industry growth are outlined in the report. The report also presents the Porter’s five forces analysis of the market which explains competitive landscape, negotiating power of buyers and suppliers, threats of new players, and arrival of substitutes in the market.
The report further presents future outlook and growth of the global market by scrutinizing the key forces that are likely to impact the market growth. The report also reveals segmental analysis by acutely assessing every segment of the global fiducial markers market. Regional market analysis of these segments is also presented in the report. The report divides the global fiducial markers market into four main regions including Europe, North America, Asia-Pacific, and LAMEA. Further, these regions are sub-divided to explain in detail the landscape of the fiducial markers market across major countries in these regions. Furthermore, the report divulges some of the recent advances, trends, and upcoming opportunities in every region.
The report offers a complete overview of 10 foremost players operating in the global fiducial markers market along with their company overview, major company executives, company’s financial status and revenue, top business activities, and groundbreaking developments in the global fiducial markers market. Besides these insights, the major events as well as strategies of major players functioning in the global fiducial markers market is also provided in the report.
RESEARCH METHODOLOGY
The report is articulated by Research Dive’s professional market analysts, and claims to be a reliable source of data and statistics for the global fiducial markers market. The market forecasts specified in the report have been derived using proven research methodologies and analytical tools & models. Use of such advanced tools helps market analysts in analyzing, filtering, and deriving precise data and predictions.
The report is formulated after a thorough conversation and interviews with top industry players, stakeholders, and market participants. All the research and analysis is based on data obtained from reliable and renowned sources of statistics, and regional intelligence. The research report is built by gathering various data points and information regarding the fiducial markers market. Primary research forms the foundation of the overall research process; however, it is reasonably supported by comprehensive secondary research. Around 5,900 product type literatures, company annual reports, market publications, and other such significant documents of key market players have been reviewed for in-depth understanding of market saturation. Additionally, trade associations’ publications, reliable industry bulletins, medical journals, and government websites have been studied for getting hold of important industry related insights.
KEY MARKET BENEFITS
- The report reveals market size and forecast for the period from 2019 to 2027
- This report sheds light on trends, inventions, and novel developments along with a detailed quantitative breakdown of the fiducial markers market during the period of forecast
- The report offers prevalent as well as upcoming investment opportunities of the global fiducial markers market
- The market size and estimations are based on a comprehensive analysis of market drivers and restraints and key improvements in the fiducial markers market
- The report also offers insights on foremost market players, Porter’s Five Analysis, and top winning business strategies
- The initiatives undertaken by the top market players are presented in the report to comprehend the competitive scenario of the market
KEY MARKET SEGMENTS
The report segments the global market into product ,end user ,modality ,cancer type and region.
- Product: Metal-based Markers, Polymer-based Markers, Other Fiducial Markers
- End User: Hospitals & Outpatient Facilities, Independent Radiotherapy Centers, Cancer Research Centers
- Modality: CT/CBCT, MRI, Ultrasound, Radiotherapy
- Cancer Type: Prostate Cancer, Lung Cancer, Breast Cancer, Gastric Cancer, Other Cancers
Regionally, the report assesses the global market across North America, Europe, Asia Pacific, and LAMEA.
- The North American countries evaluated in the report are the U.S., Canada, and Mexico
- The European countries evaluated in the report are Germany, UK, France, Spain, Italy, and Rest of Europe
- The Asian countries evaluated in the report are Japan, China, India, Australia, and Rest of Asia-Pacific
- The countries in LAMEA evaluated in the report are Brazil, Saudi Arabia, South Africa, South Korea, and Rest of LAMEA
KEY PLAYERS
The key players outlined in the report are Medtronic, QlRad Inc., CIVCO Radiotherapy, Carbon Medical Technologies.
The report summaries the business overview including financial performance, latest strategic moves & developments, product portfolio, and SWOT analysis of the top players functioning in the fiducial markers market.
1. CIVCO Radiotherapy
2. IZI Medical Products
3. Boston Scientific Corporation
4. Naslund Medical AB
5. IBA
6. Best Medical International, Inc.
7. Nanovi A/S
8. Carbon Medical Technologies
9. Eckert & Ziegler
10. Innovative Oncology Solutions
11. Medtronic
12. QlRad Inc.
13. JJ-Medtech
14. QFIX
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Fiducial Markers Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Fiducial Markers Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Fiducial Markers Market, By End Use
5.1. Overview
5.2 Metal-based Markers
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Polymer-based Markers
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Other Fiducial Markers
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Research Dive Exclusive Insights
5.5.1 Market attractiveness
5.5.2 Competition heatmap
-
6. Fiducial Markers Market, By Distribution Channel
6.1. Overview
6.2 Hospitals & Outpatient Facilities
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Independent Radiotherapy Centers
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Cancer Research Centers
6.4.1 Definition, key trends, growth factors, and opportunities
6.4.2 Market size analysis, by region, 2020-2027
6.4.3 Market share analysis, by country, 2020-2027
6.5 Research Dive Exclusive Insights
6.5.1 Market attractiveness
6.5.2 Competition heatmap
-
7. Fiducial Markers Market, By Type Of Vaccine
7.1. Overview
7.2 CT/CBCT
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 MRI
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Ultrasound
7.4.1 Definition, key trends, growth factors, and opportunities
7.4.2 Market size analysis, by region, 2020-2027
7.4.3 Market share analysis, by country, 2020-2027
7.5 Radiotherapy
7.5.1 Definition, key trends, growth factors, and opportunities
7.5.2 Market size analysis, by region, 2020-2027
7.5.3 Market share analysis, by country, 2020-2027
7.6 Research Dive Exclusive Insights
7.6.1 Market attractiveness
7.6.2 Competition heatmap
-
8. Fiducial Markers Market, By Grade Type
8.1. Overview
8.2 Prostate Cancer
8.2.1 Definition, key trends, growth factors, and opportunities
8.2.2 Market size analysis, by region, 2020-2027
8.2.3 Market share analysis, by country, 2020-2027
8.3 Lung Cancer
8.3.1 Definition, key trends, growth factors, and opportunities
8.3.2 Market size analysis, by region, 2020-2027
8.3.3 Market share analysis, by country, 2020-2027
8.4 Breast Cancer
8.4.1 Definition, key trends, growth factors, and opportunities
8.4.2 Market size analysis, by region, 2020-2027
8.4.3 Market share analysis, by country, 2020-2027
8.5 Gastric Cancer
8.5.1 Definition, key trends, growth factors, and opportunities
8.5.2 Market size analysis, by region, 2020-2027
8.5.3 Market share analysis, by country, 2020-2027
8.6 Other Cancers
8.6.1 Definition, key trends, growth factors, and opportunities
8.6.2 Market size analysis, by region, 2020-2027
8.6.3 Market share analysis, by country, 2020-2027
8.7 Research Dive Exclusive Insights
8.7.1 Market attractiveness
8.7.2 Competition heatmap
9. Fiducial Markers Market, By Region
9.1 North America
9.1.1 U.S
9.1.1.1 Market size analysis, By End Use, 2020-2027
9.1.1.2 Market size analysis, By Distribution Channel, 2020-2027
9.1.1.3 Market size analysis, By Type of Vaccine, 2020-2027
9.1.1.4 Market size analysis, By Grade Type, 2020-2027
9.1.2 Canada
9.1.2.1 Market size analysis, By End Use, 2020-2027
9.1.2.2 Market size analysis, By Distribution Channel, 2020-2027
9.1.2.3 Market size analysis, By Type of Vaccine, 2020-2027
9.1.2.4 Market size analysis, By Grade Type, 2020-2027
9.1.3 Mexico
9.1.3.1 Market size analysis, By End Use, 2020-2027
9.1.3.2 Market size analysis, By Distribution Channel, 2020-2027
9.1.3.3 Market size analysis, By Type of Vaccine, 2020-2027
9.1.3.4 Market size analysis, By Grade Type, 2020-2027
9.1.4 Research Dive Exclusive Insights
9.1.4.1 Market attractiveness
9.1.4.2 Competition heatmap
9.2 Europe
9.2.1 Germany
9.2.1.1 Market size analysis, By End Use, 2020-2027
9.2.1.2 Market size analysis, By Distribution Channel, 2020-2027
9.2.1.3 Market size analysis, By Type of Vaccine, 2020-2027
9.2.1.4 Market size analysis, By Grade Type, 2020-2027
9.2.2 UK
9.2.2.1 Market size analysis, By End Use, 2020-2027
9.2.2.2 Market size analysis, By Distribution Channel, 2020-2027
9.2.2.3 Market size analysis, By Type of Vaccine, 2020-2027
9.2.2.4 Market size analysis, By Grade Type, 2020-2027
9.2.3 France
9.2.3.1 Market size analysis, By End Use, 2020-2027
9.2.3.2 Market size analysis, By Distribution Channel, 2020-2027
9.2.3.3 Market size analysis, By Type of Vaccine, 2020-2027
9.2.3.4 Market size analysis, By Grade Type, 2020-2027
9.2.4 Spain
9.2.4.1 Market size analysis, By End Use, 2020-2027
9.2.4.2 Market size analysis, By Distribution Channel, 2020-2027
9.2.4.3 Market size analysis, By Type of Vaccine, 2020-2027
9.2.4.4 Market size analysis, By Grade Type, 2020-2027
9.2.5 Italy
9.2.5.1 Market size analysis, By End Use, 2020-2027
9.2.5.2 Market size analysis, By Distribution Channel, 2020-2027
9.2.5.3 Market size analysis, By Type of Vaccine, 2020-2027
9.2.5.4 Market size analysis, By Grade Type, 2020-2027
9.2.6 Rest of Europe
9.2.6.1 Market size analysis, By End Use, 2020-2027
9.2.6.2 Market size analysis, By Distribution Channel, 2020-2027
9.2.6.3 Market size analysis, By Type of Vaccine, 2020-2027
9.2.6.4 Market size analysis, By Grade Type, 2020-2027
9.2.7 Research Dive Exclusive Insights
9.2.7.1 Market attractiveness
9.2.7.2 Competition heatmap
9.3 Asia-Pacific
9.3.1 China
9.3.1.1 Market size analysis, By End Use, 2020-2027
9.3.1.2 Market size analysis, By Distribution Channel, 2020-2027
9.3.1.3 Market size analysis, By Type of Vaccine, 2020-2027
9.3.1.4 Market size analysis, By Grade Type, 2020-2027
9.3.2 Japan
9.3.2.1 Market size analysis, By End Use, 2020-2027
9.3.2.2 Market size analysis, By Distribution Channel, 2020-2027
9.3.2.3 Market size analysis, By Type of Vaccine, 2020-2027
9.3.2.4 Market size analysis, By Grade Type, 2020-2027
9.3.3 India
9.3.3.1 Market size analysis, By End Use, 2020-2027
9.3.3.2 Market size analysis, By Distribution Channel, 2020-2027
9.3.3.3 Market size analysis, By Type of Vaccine, 2020-2027
9.3.3.4 Market size analysis, By Grade Type, 2020-2027
9.3.4 Australia
9.3.4.1 Market size analysis, By End Use, 2020-2027
9.3.4.2 Market size analysis, By Distribution Channel, 2020-2027
9.3.4.3 Market size analysis, By Type of Vaccine, 2020-2027
9.3.4.4 Market size analysis, By Grade Type, 2020-2027
9.3.5 South Korea
9.3.5.1 Market size analysis, By End Use, 2020-2027
9.3.5.2 Market size analysis, By Distribution Channel, 2020-2027
9.3.5.3 Market size analysis, By Type of Vaccine, 2020-2027
9.3.5.4 Market size analysis, By Grade Type, 2020-2027
9.3.6 Rest of Asia-Pacific
9.3.6.1 Market size analysis, By End Use, 2020-2027
9.3.6.2 Market size analysis, By Distribution Channel, 2020-2027
9.3.6.3 Market size analysis, By Type of Vaccine, 2020-2027
9.3.6.4 Market size analysis, By Grade Type, 2020-2027
9.3.7 Research Dive Exclusive Insights
9.3.7.1 Market attractiveness
9.3.7.2 Competition heatmap
9.4 LAMEA
9.4.1 Brazil
9.4.1.1 Market size analysis, By End Use, 2020-2027
9.4.1.2 Market size analysis, By Distribution Channel, 2020-2027
9.4.1.3 Market size analysis, By Type of Vaccine, 2020-2027
9.4.1.4 Market size analysis, By Grade Type, 2020-2027
9.4.2 Saudi Arabia
9.4.2.1 Market size analysis, By End Use, 2020-2027
9.4.2.2 Market size analysis, By Distribution Channel, 2020-2027
9.4.2.3 Market size analysis, By Type of Vaccine, 2020-2027
9.4.2.4 Market size analysis, By Grade Type, 2020-2027
9.4.3 UAE
9.4.3.1 Market size analysis, By End Use, 2020-2027
9.4.3.2 Market size analysis, By Distribution Channel, 2020-2027
9.4.3.3 Market size analysis, By Type of Vaccine, 2020-2027
9.4.3.4 Market size analysis, By Grade Type, 2020-2027
9.4.4 South Africa
9.4.4.1 Market size analysis, By End Use, 2020-2027
9.4.4.2 Market size analysis, By Distribution Channel, 2020-2027
9.4.4.3 Market size analysis, By Type of Vaccine, 2020-2027
9.4.4.4 Market size analysis, By Grade Type, 2020-2027
9.4.5 Rest of LAMEA
9.4.5.1 Market size analysis, By End Use, 2020-2027
9.4.5.2 Market size analysis, By Distribution Channel, 2020-2027
9.4.5.3 Market size analysis, By Type of Vaccine, 2020-2027
9.4.5.4 Market size analysis, By Grade Type, 2020-2027
9.4.6 Research Dive Exclusive Insights
9.4.6.1 Market attractiveness
9.4.6.2 Competition heatmap
10. Competitive Landscape
10.1 Top winning strategies, 2020-2027
10.1.1 By strategy
10.1.2 By year
10.2 Strategic overview
10.3 Market share analysis, 2020-2027
11. Company Profiles
11.1 CIVCO Radiotherapy
11.1.1 Overview
11.1.2 Business segments
11.1.3 Product portfolio
11.1.4 Financial performance
11.1.5 Recent developments
11.1.6 SWOT analysis
11.2 IZI Medical Products
11.2.1 Overview
11.2.2 Business segments
11.2.3 Product portfolio
11.2.4 Financial performance
11.2.5 Recent developments
11.2.6 SWOT analysis
11.3 Boston Scientific Corporation
11.3.1 Overview
11.3.2 Business segments
11.3.3 Product portfolio
11.3.4 Financial performance
11.3.5 Recent developments
11.3.6 SWOT analysis
11.4 Naslund Medical AB
11.4.1 Overview
11.4.2 Business segments
11.4.3 Product portfolio
11.4.4 Financial performance
11.4.5 Recent developments
11.4.6 SWOT analysis
11.5 IBA
11.5.1 Overview
11.5.2 Business segments
11.5.3 Product portfolio
11.5.4 Financial performance
11.5.5 Recent developments
11.5.6 SWOT analysis
11.6 Best Medical International, Inc.
11.6.1 Overview
11.6.2 Business segments
11.6.3 Product portfolio
11.6.4 Financial performance
11.6.5 Recent developments
11.6.6 SWOT analysis
11.7 Nanovi A/S
11.7.1 Overview
11.7.2 Business segments
11.7.3 Product portfolio
11.7.4 Financial performance
11.7.5 Recent developments
11.7.6 SWOT analysis
11.8 Carbon Medical Technologies
11.8.1 Overview
11.8.2 Business segments
11.8.3 Product portfolio
11.8.4 Financial performance
11.8.5 Recent developments
11.8.6 SWOT analysis
11.9 Eckert & Ziegler
11.9.1 Overview
11.9.2 Business segments
11.9.3 Product portfolio
11.9.4 Financial performance
11.9.5 Recent developments
11.9.6 SWOT analysis
11.10 Innovative Oncology Solutions
11.10.1 Overview
11.10.2 Business segments
11.10.3 Product portfolio
11.10.4 Financial performance
11.10.5 Recent developments
11.10.6 SWOT analysis
11.11 Medtronic
11.11.1 Overview
11.11.2 Business segments
11.11.3 Product portfolio
11.11.4 Financial performance
11.11.5 Recent developments
11.11.6 SWOT analysis
11.12 QlRad Inc.
11.12.1 Overview
11.12.2 Business segments
11.12.3 Product portfolio
11.12.4 Financial performance
11.12.5 Recent developments
11.12.6 SWOT analysis
11.13 JJ-Medtech
11.13.1 Overview
11.13.2 Business segments
11.13.3 Product portfolio
11.13.4 Financial performance
11.13.5 Recent developments
11.13.6 SWOT analysis
11.14 QFIX
11.14.1 Overview
11.14.2 Business segments
11.14.3 Product portfolio
11.14.4 Financial performance
11.14.5 Recent developments
11.14.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
